about
Use of procalcitonin and C-reactive protein to evaluate vaccine efficacy against pneumoniaChlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trialPersistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment programProspective cohort study comparing seasonal and H1N1(2009) pandemic influenza virus illnesses in HIV-infected children during 2009.Data Management and Data Quality in PERCH, a Large International Case-Control Study of Severe Childhood PneumoniaContribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials.Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa.Influenza vaccination of pregnant women and protection of their infants.Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads.Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infantsIncreased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1).Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their InfantsClinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children.Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.Polyomaviruses-associated respiratory infections in HIV-infected and HIV-uninfected children.Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine.Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization--in HIV-Infected and HIV-uninfected childreMaternal HIV infection and vertical transmission of pathogenic bacteria.Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety.Seasonality, incidence, and repeat human metapneumovirus lower respiratory tract infections in an area with a high prevalence of human immunodeficiency virus type-1 infection.Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children.Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children.Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa.Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa.The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia.Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination.Chlorhexidine Maternal-Vaginal and Neonate Body Wipes in Sepsis and Vertical Transmission of Pathogenic Bacteria in South Africa: A Randomized, Controlled TrialInfluenza Vaccination of Pregnant Women and Protection of Their InfantsPneumococcal Coinfection with Human MetapneumovirusSocial franchising of community-based HIV testing and linkage to HIV care and treatment services: an evaluation of a pilot study in Tshwane, South Africa
P50
Q24794396-8E48082D-B622-4917-90E0-9E97F8621390Q28262067-A702A6B4-B216-47DB-B90D-02F08827C27FQ28742203-FD0289D1-D3BB-45C9-B318-41CC58F07889Q30352523-9CD5FF2D-918D-48EF-AFC9-2E0D8A2E34BBQ30853897-6B361B01-D5C3-4306-8D67-8AF7D0B1D753Q33737096-AA43EABF-A3D2-47F9-8898-8457CAE85BA5Q34124926-8BEEB4C8-7B95-4F19-A300-C919DFB1A534Q34436687-C0D940E3-D1A8-4D23-9206-19BBBD02F305Q34704088-B8CC6A99-2AA7-4E3F-BD00-D6FC9C9739D8Q34981631-A029A666-46E8-4BA6-95BE-3A9D354B5FE4Q35229614-E1942DD6-1A11-48C5-9CD5-24BF6F6ED00AQ36306940-E0CEC9C3-2297-4DFA-9D2C-E1C05C13F1ACQ37548453-4E27DFE5-6DDD-4D34-B55F-B73E63F56ACAQ41581352-33F8993D-636D-414D-9522-828591DB4707Q41622579-D45896BF-E375-43F8-B517-30134449C967Q42247242-3216CA88-EB7F-4D77-A143-FA4FA17AD795Q43978300-E04A0CAF-297A-46C2-8AF4-B2FEC5FF6B74Q44223713-741BA3C8-921B-4CF3-9242-4C8C80D11BE4Q44702826-B6E945F5-8358-41E3-8462-B2F79ABC35BCQ44992787-FF21853A-44E3-4BEA-94D7-AEC302094559Q45370567-74BD2F5E-73E8-4EAE-9411-6A4D257D9609Q45400150-33680B6E-B5A4-40FB-8114-14505163730CQ45411475-A0C9DC9F-D9A6-4206-A45B-286FE178E6A3Q45416972-4A125F10-ADDC-4A8E-959D-5980BFF4779DQ45469643-3D395779-749E-4DC8-BFA6-968744F709FEQ46418931-C6738291-627A-4090-B7C3-EF2DA1B21342Q46853559-4CA3EFA6-D2AE-4A9A-96AC-876CB3F2A964Q46973033-DD791D8C-E5B2-4257-A472-4B866549A0E7Q47659607-869C016C-91A4-4D83-8CB4-717049F75B01Q51781652-6B116797-7938-43ED-90CF-A877D18B4CFFQ58014078-6DA0FC78-A526-40E4-8049-9DC785DA5131Q58052651-BD77BD43-E123-44AD-9422-D3E0C82A3FD9Q58052660-8A26B4B9-B04B-4D50-8369-921C6F5F3EC4Q60944141-F279CA58-6E07-4958-9A19-598E73192BE5
P50
name
Locadiah Kuwanda
@en
Locadiah Kuwanda
@nl
type
label
Locadiah Kuwanda
@en
Locadiah Kuwanda
@nl
prefLabel
Locadiah Kuwanda
@en
Locadiah Kuwanda
@nl